Clinical Trials

Clinical trials in nuclear medicine. Sorted by date of last update.

Title	Phase	Last Update
Dose-Escalation Study of Cabozantinib in Combination with Lutetium-177 (Lu-177)-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (CaboLu) Phase 1 Last update: October 31	Phase 1	October 31
An Open-label Study Comparing Lutetium (Lu-177) Vipivotide Tetraxetan versus Observation in PSMA Positive OMPC. (PSMA-DC) Phase 3 Last update: October 31	Phase 3	October 31
Comparing Retreatment of Lu-177-DOTATATE PRRT versus the Usual Treatment in Patients with Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial Phase 2 Last update: October 31	Phase 2	October 31
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer Phase 1 Last update: October 31	Phase 1	October 31
XL092 in Patients with Metastatic Castration-Resistant Prostate Cancer (PRO-XL) Phase 2 Last update: October 31	Phase 2	October 31
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study Phase 2 Last update: October 31	Phase 2	October 31
A Study of Lu-177-PSMA-617 in People with Gliomas Phase 1 Last update: October 31	Phase 1	October 31
Testing Lutetium Lu-177 Dotatate in Patients with Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors Phase 2 Last update: October 30	Phase 2	October 30
Low-Count Quantitative SPECT for Men Treated with Radium-223 N/A Last update: October 30	N/A	October 30
Lu-177-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) with Bone Marrow Involvement and Cytopenia Phase 2 Last update: October 30	Phase 2	October 30